BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26838319)

  • 1. RhoA/Rho-Kinase in the Cardiovascular System.
    Shimokawa H; Sunamura S; Satoh K
    Circ Res; 2016 Jan; 118(2):352-66. PubMed ID: 26838319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
    Shimokawa H; Satoh K
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light and Dark of Reactive Oxygen Species for Vascular Function: 2014 ASVB (Asian Society of Vascular Biology).
    Shimokawa H; Satoh K
    J Cardiovasc Pharmacol; 2015 May; 65(5):412-8. PubMed ID: 25162437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase: important new therapeutic target in cardiovascular diseases.
    Satoh K; Fukumoto Y; Shimokawa H
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H287-96. PubMed ID: 21622831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the RhoA/rho-kinase pathway in pulmonary hypertension.
    Nossaman BD; Kadowitz PJ
    Curr Drug Discov Technol; 2009 Mar; 6(1):59-71. PubMed ID: 19275543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological effects of RhoA and Rho-associated kinase on cardiovascular system.
    Cai A; Li L; Zhou Y
    J Hypertens; 2016 Jan; 34(1):3-10. PubMed ID: 26556565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats.
    Sari AN; Kacan M; Unsal D; Sahan Firat S; Kemal Buharalioglu C; Vezir O; Korkmaz B; Cuez T; Canacankatan N; Sucu N; Ayaz L; Tamer Gumus L; Gorur A; Tunctan B
    Eur J Pharmacol; 2014 Jan; 723():234-45. PubMed ID: 24296316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho kinase and hypertension.
    Wirth A
    Biochim Biophys Acta; 2010 Dec; 1802(12):1276-84. PubMed ID: 20460153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
    Calò LA; Pessina AC
    J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase is an important therapeutic target in cardiovascular medicine.
    Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress of the study of rho-kinase and future perspective of the inhibitor.
    Tawara S; Shimokawa H
    Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular rho kinases and their potential therapeutic applications.
    Budzyn K; Sobey CG
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):590-6. PubMed ID: 17786858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.
    Zhou H; Li YJ
    Curr Pharm Des; 2012; 18(20):2964-73. PubMed ID: 22571664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
    Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.
    Lu QY; Chen W; Lu L; Zheng Z; Xu X
    Int J Clin Exp Pathol; 2014; 7(10):7268-77. PubMed ID: 25400825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
    Shi J; Wei L
    J Cardiovasc Pharmacol; 2013 Oct; 62(4):341-54. PubMed ID: 23921309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA/Rho-kinase and vascular diseases: what is the link?
    Nunes KP; Rigsby CS; Webb RC
    Cell Mol Life Sci; 2010 Nov; 67(22):3823-36. PubMed ID: 20668910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA/Rho-kinase as a therapeutic target in asthma.
    Kume H
    Curr Med Chem; 2008; 15(27):2876-85. PubMed ID: 18991642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.
    Barman SA; Zhu S; White RE
    Vasc Health Risk Manag; 2009; 5():663-71. PubMed ID: 19707285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.